<?xml version="1.0" encoding="UTF-8"?>
<p>Infections of grade III or higher were significantly associated with type of treatment, affecting 19% of the CLB-treated patients and 30% in the FCR group (
 <italic>P</italic>=0.006) (
 <xref rid="t2-1040797" ref-type="table">Table 2</xref>). Richter transformation occurred in 5.5% of the patients, was significantly associated with del(17p) (
 <italic>P</italic>=0.04), and was equally distributed between types of first-line therapy. The median time to transformation was three years from diagnosis and 1.5 years from first-line treatment. Secondary malignancies affected 15% of the patients and were equally distributed between types of first-line therapy. About one-third of the secondary malignancies consisted of basal cell carcinomas. MDS/AML affected only 1% of the patients and the other secondary malignancies were solid tumors.
</p>
